BEST-CLI is an international research study aimed at figuring out the best treatment for people with peripheral arterial disease (PAD) - also known as poor blood flow, and associated with Critical Limb Ischemia (CLI). It is Federally funded by the National Heart, Lung and Blood Institute at the National Institutes of Health.
As of November 2022, BEST-CLI enrollment ended in October of 2019, and completed a minimum of 24 months' follow-up for all patients in October of 2021. The primary
[...]